Research on the Collaborative Supervision Mechanism of Medical Insurance Fund for Cross-Regional Medical Treatment

China Health Insurance ›› 2025, Vol. 0 ›› Issue (4) : 75-81.

China Health Insurance ›› 2025, Vol. 0 ›› Issue (4) : 75-81. DOI: 10.19546/j.issn.1674-3830.2025.4.010
Management Platform

Research on the Collaborative Supervision Mechanism of Medical Insurance Fund for Cross-Regional Medical Treatment

Author information +
History +

Abstract

With the rapid development of China's economy and society, population mobility has become increasingly frequent, and the scale of cross-regional medical treatment continues to expand. This presents new challenges for healthcare security, particularly in the supervision of cross-regional medical services. In the context of medical treatment received outside one's hometown, the supervision of medical insurance funds involves different regions and multiple departments, and it is necessary to form an effective collaborative regulatory force. Improving the coordination mechanism for medical insurance fund supervision is an effective means to address the difficulties in supervising medical treatment received outside one's hometown. Based on the theories of collaborative governance, principal-agent, and information sharing, this paper thoroughly analyzes the current difficulties in the coordinated supervision of medical insurance funds for medical treatment received outside one's hometown and proposes specific suggestions for establishing and improving the coordinated supervision mechanism of medical insurance funds.

Key words

healthcare security / medical insurance funds / cross-regional medical treatment / healthcare security supervision

Cite this article

Download Citations
Research on the Collaborative Supervision Mechanism of Medical Insurance Fund for Cross-Regional Medical Treatment[J]. China Health Insurance. 2025, 0(4): 75-81 https://doi.org/10.19546/j.issn.1674-3830.2025.4.010

References

[1] 国家医疗保障局.2024年医疗保障事业发展统计快报[EB/OL].(2025-03-21)[2025-03-21].https://www.nhsa.gov.cn/art/2024/7/25/art_7_13340.html.
[2] 陈虹伊.加强异地医保基金监管对财政支出的影响分析[J].环渤海经济瞭望,2024(06):107-110.
[3] 何靖冉,康正,陈方厅,等.异地就医下医保基金监管困境及应对策略的质性研究[J].中国医院管理,2024,44(04):23-28.
[4] 王煜昊,王丽娜,梁丽蕙,等.跨省异地就医的医保基金监管路径研究[J].卫生经济研究,2023,40(04):61-65+69.
[5] 张敏,吴胤歆.我国医保基金的协同度测量与优化路径研究——基于SFIC模型[J].中国卫生政策研究,2023,16(10):41-48.
[6] 人社部部署跨省异地就医直接结算工作[J].中国医疗保险,2017(01):71.
[7] 曹凯.医保飞检——五年建制[J].中国医院院长,2023,19(20):38-44.
[8] 北京市医疗保障局,北京市人力资源和社会保障局.关于落实《国家基本医疗保险、工伤保险和生育保险药品目录(2022年)》有关问题的通知[J].北京市人民政府公报,2023(23):63-75.
[9] 最高人民法院公报.最高人民法院关于适用《中华人民共和国刑事诉讼法》的解释[M].北京:法律出版社,2021.

Accesses

Citation

Detail

Sections
Recommended

/